Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism

Abstract Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer following invasive ductal carcinoma (IDC). ILC differs from IDC in a number of histological and clinical features, such as single strand growth, difficulty in detection, and frequent late recurr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tian Du, Li Zhu, Kevin M. Levine, Nilgun Tasdemir, Adrian V. Lee, Dario A. A. Vignali, Bennett Van Houten, George C. Tseng, Steffi Oesterreich
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/c6d543ab51884631b6b934f41303a8d0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c6d543ab51884631b6b934f41303a8d0
record_format	dspace
spelling	oai:doaj.org-article:c6d543ab51884631b6b934f41303a8d02021-12-02T16:07:51ZInvasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism10.1038/s41598-018-25357-02045-2322https://doaj.org/article/c6d543ab51884631b6b934f41303a8d02018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25357-0https://doaj.org/toc/2045-2322Abstract Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer following invasive ductal carcinoma (IDC). ILC differs from IDC in a number of histological and clinical features, such as single strand growth, difficulty in detection, and frequent late recurrences. To understand the molecular pathways involved in the clinical characteristics of ILC, we compared the gene expression profiles of luminal A ILC and luminal A IDC using data from TCGA and utilized samples from METABRIC as a validation data set. Top pathways that were significantly enriched in ILC were related to immune response. ILC exhibited a higher activity of almost all types of immune cells based on cell type-specific signatures compared to IDC. Conversely, pathways that were less enriched in ILC were related to protein translation and metabolism, which we functionally validated in cell lines. The higher immune activity uncovered in our study highlights the currently unexplored potential of a response to immunotherapy in a subset of patients with ILC. Furthermore, the lower rates of protein translation and metabolism - known features of tumor dormancy - may play a role in the late recurrences of ILC and lower detection rate in mammography and PET scanning.Tian DuLi ZhuKevin M. LevineNilgun TasdemirAdrian V. LeeDario A. A. VignaliBennett Van HoutenGeorge C. TsengSteffi OesterreichNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Tian Du Li Zhu Kevin M. Levine Nilgun Tasdemir Adrian V. Lee Dario A. A. Vignali Bennett Van Houten George C. Tseng Steffi Oesterreich Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
description	Abstract Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer following invasive ductal carcinoma (IDC). ILC differs from IDC in a number of histological and clinical features, such as single strand growth, difficulty in detection, and frequent late recurrences. To understand the molecular pathways involved in the clinical characteristics of ILC, we compared the gene expression profiles of luminal A ILC and luminal A IDC using data from TCGA and utilized samples from METABRIC as a validation data set. Top pathways that were significantly enriched in ILC were related to immune response. ILC exhibited a higher activity of almost all types of immune cells based on cell type-specific signatures compared to IDC. Conversely, pathways that were less enriched in ILC were related to protein translation and metabolism, which we functionally validated in cell lines. The higher immune activity uncovered in our study highlights the currently unexplored potential of a response to immunotherapy in a subset of patients with ILC. Furthermore, the lower rates of protein translation and metabolism - known features of tumor dormancy - may play a role in the late recurrences of ILC and lower detection rate in mammography and PET scanning.
format	article
author	Tian Du Li Zhu Kevin M. Levine Nilgun Tasdemir Adrian V. Lee Dario A. A. Vignali Bennett Van Houten George C. Tseng Steffi Oesterreich
author_facet	Tian Du Li Zhu Kevin M. Levine Nilgun Tasdemir Adrian V. Lee Dario A. A. Vignali Bennett Van Houten George C. Tseng Steffi Oesterreich
author_sort	Tian Du
title	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
title_short	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
title_full	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
title_fullStr	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
title_full_unstemmed	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
title_sort	invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/c6d543ab51884631b6b934f41303a8d0
work_keys_str_mv	AT tiandu invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT lizhu invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT kevinmlevine invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT nilguntasdemir invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT adrianvlee invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT darioaavignali invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT bennettvanhouten invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT georgectseng invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism AT steffioesterreich invasivelobularandductalbreastcarcinomadifferinimmuneresponseproteintranslationefficiencyandmetabolism
_version_	1718384744255717376

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism

Ejemplares similares